Baumer S.A.

BVMF-BALM3
Brazil Stock Exchange
Healthcare Medical Instruments & Supplies
Global Rank
#32942
Country Rank
#281
Market Cap
32.39 M
Price
3.68
Change (%)
0.00%
Volume
3,100

Baumer S.A.'s latest marketcap:

32.39 M

As of 07/05/2025, Baumer S.A.'s market capitalization has reached $32.39 M. According to our data, Baumer S.A. is the 32942th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 32.39 M
Revenue (ttm) 38.13 M
Net Income (ttm) 5.7 M
Shares Out 0
EPS (ttm) 0.58
Forward PE 0.00
Ex-Dividend Date 05/07/2025
Earnings Date 08/14/2025
Market Cap Chart
Data Updated: 07/05/2025

Baumer S.A.'s yearly market capitalization.

Baumer S.A. has seen its market value drop from R$117.6 M to R$32.39 M since 2014, representing a total decrease of 72.46% and an annual compound decline rate (CAGR) of 11.50%.
Date Market Cap Change (%) Global Rank
07/05/2025 R$32.39 M 50% 32942
12/30/2024 R$117.41 M 6.56% 34527
12/28/2023 R$110.18 M 4.27% 32981
12/29/2022 R$105.67 M -24.42% 32639
12/30/2021 R$139.81 M -21.53% 31595
12/30/2020 R$178.16 M 70.98% 26852
12/30/2019 R$104.2 M -14.71% 25268
12/03/2018 R$122.18 M 46.04% 23383
12/28/2017 R$83.66 M 5.14% 24645
12/19/2016 R$79.58 M -10.57% 22513

Company Profile

About Baumer S.A.

Baumer S.A. is a Brazilian company specializing in the development, production, and distribution of medical products for hospitals, healthcare industries, and orthopedic and dental surgeries. Founded in 1952 and headquartered in Pacaembu, Brazil, the company provides a wide range of solutions to support healthcare professionals.

Products & Services

  • Bone Regeneration Drugs: Includes membranes and grafts for surgical applications.
  • Healthcare Equipment: Covers safe environment solutions, disinfection, water treatment, sterilization, surgical room tools, and cleaning systems.
  • Orthopedic Devices: Offers conventional and non-conventional prostheses, trauma solutions, neurosurgery tools, and bone cement.
  • Support Services: Provides maintenance, sterilization, upgrades, equipment rental, training, and product servicing.

Baumer S.A. plays a vital role in advancing medical technology and improving patient care across Brazil.

Frequently Asked Questions

  • What is Baumer S.A.'s (BVMF-BALM3) current market cap?
    As of 07/05/2025, Baumer S.A. (including the parent company, if applicable) has an estimated market capitalization of $32.39 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
  • Baumer S.A. global market capitalization ranking is approximately 32942 as of 07/05/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.